PGen will put in certain know-how and trade secrets including its patented, Elastatropin human based protein, into the collaboration. American CryoStem will contribute certain intellectual property, know-how and
In the multicenter, open-label extension study reported no serious adverse events that were considered drug-related. The most common adverse events that arose during the trial were diarrhea (9.6%),
The randomized, double-blinded, placebo-controlled study met its primary endpoint of a dose-responsive increase in hemoglobin from baseline over the 42 days of the study (p<0.0001). The results show
The filing was based on the Phase III VELOUR study in patients with metastatic colorectal cancer previously treated with an oxaliplatin-containing regimen. The companies have also announced the
Mylan alleges Teva did not keep up valid paragraph IV certifications as a result of its purchase of Cephalon and the FDA should have found Mylan as the
As per the agreement, Zambon will initially invest €20m into Newron, covering the completion of safinamide’s clinical development and the preparation of the application for marketing approval in
The patent is directed to composition and formulations of the XP23829 compound and another patent application directed to therapeutic uses of XP23829 is now pending, the company said.
The Court has ruled that the asserted claims of US patents 7,410,978 , 7,759,359, 7,781,448, 7,781,449 and 7,763,635 for Sanctura XR are invalid. Sanctura XR is indicated for
Diabetrol consists of 16 natural vitamin ingredients, formulated to help provide blood sugar protection. The advanced vitamin supplement can bring back blood sugar levels to a healthy level
Under the partnership, the companies will combine their skills and expertise with the goal of initiating clinical trials of Edge’s portfolio of therapies that use implantable technology to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.